pfizer glp 1 oral discontinues GLP-1 receptor agonist danuglipron Pfizer Provides Update on Oral

Diabetologia (1979) 16:7585

[67] CHIP, Medicaid, and Medicare Coverage [edit] In April 2025, the Trump Administration declined to finalize a Biden Administration proposal that would have required Medicare, Medicaid, and the Children's Health Insurance Program (CHIP) to broadly cover GLP-1 drugs for weight loss

When you lose weight quickly, you often lose both fat and muscle, especially without adequate protein intake and strength training

The decision to prescribe these medications considers your overall cardiovascular risk profile, not just your blood glucose levels

Research on Eli Lillys orforglipron is ongoing, so efficacy data isnt available yet

This program is about supporting consistency, not forcing outcomes